INHIBITORY EFFECTS OF COMMONLY USED HERBAL EXTRACTS ON UGT1A4. 1A6, AND 1A9 ENZYME ACTIVITIES

被引：0
|
作者：
Mohamed, M. F. [1 ]
Frye, R. F. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [11] Effect of chrysin and natural coumarins on UGT1A1 and 1A6 activities in rat and human hepatocytes in primary culture
    Chlouchi, Amina
    Girard, Corinne
    Bonet, Alexandre
    Viollon-Abadie, Catherine
    Heyd, Bruno
    Mantion, Georges
    Martin, Helene
    Richert, Lysiane
    PLANTA MEDICA, 2007, 73 (08) : 742 - 747
  • [12] Characterizing the Effects of Common UDP Glucuronosyltransferase (UGT) 1A6 and UGT1A1 Polymorphisms on cis- and trans-Resveratrol Glucuronidation
    Iwuchukwu, Otito Frances
    Ajetunmobi, Jumoke
    Ung, Din
    Nagar, Swati
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1726 - 1732
  • [13] Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities
    Fujiwara, Ryoichi
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (10) : 1781 - 1787
  • [14] Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms
    Fujiwara, Ryoichi
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Nakamura, Akiko
    Katoh, Miki
    Ikushiro, Shin-ichi
    Sakaki, Toshiyuki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (05) : 747 - 757
  • [15] Inhibitory Effects of Endogenous Linoleic Acid and Glutaric Acid on the Renal Glucuronidation of Berberrubine in Mice and on Recombinant Human UGT1A7, 1A8, and 1A9
    Yang, Na
    Li, Sijia
    Yan, Caixia
    Sun, Runbin
    He, Jun
    Xie, Yuan
    Peng, Ying
    Wang, Guangji
    Aa, Jiye
    MOLECULAR PHARMACOLOGY, 2018, 93 (03) : 216 - 227
  • [16] The "Albumin Effect" and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
    Rowland, Andrew
    Knights, Kathleen M.
    Mackenzie, Peter I.
    Miners, John O.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 1056 - 1062
  • [17] THYROXINE GLUCURONIDATIONS IN HUMAN LIVER, JEJUNUM, AND KIDNEY MICROSOMES WERE CATALYZED BY UGT1A1, 1A7, 1A8, 1A9, AND 1A10: EFFECTS OF UGT-UGT INTERACTIONS
    Yamanaka, Hiroyuki
    Nakajima, Miki
    Fujiwara, Ryoichi
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM REVIEWS, 2007, 39 : 184 - 185
  • [18] Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in β-thalassemia/HbE
    Tankanitlert, Jeeranut
    Morales, Noppawan Phumala
    Howard, Thad A.
    Fucharoen, Pranee
    Ware, Russell E.
    Fucharoen, Suthat
    Chantharaksri, Udom
    PHARMACOLOGY, 2007, 79 (02) : 97 - 103
  • [19] Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin
    Gao, Chengcheng
    Xie, Rui
    Ma, Tianheng
    Yan, Wei
    Pang, Liqun
    AFRICAN HEALTH SCIENCES, 2013, 13 (03) : 551 - 555
  • [20] Roles of N-Terminal Domain Histidine and Proline Residues in the Substrate Selectivities of Human UDP-Glucuronosyltransferase (UGT) 1A1, 1A6, 1A9, 2B7, and 2B10
    Kerdpin, Oranun
    Mackenzie, Peter I.
    Bowalgaha, Kushari
    Finel, Moshe
    Miners, John O.
    DRUG METABOLISM REVIEWS, 2009, 41 : 70 - 71
12345